EMILY TULL: Open Payments
NPI 1386137586 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,367 in 76 payments from 21 companies in 2025. Trend: 2023 $198 · 2024 $620 · 2025 $1,367
Food & beverage: $1,367
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $184 |
| AstraZeneca Pharmaceuticals LP | 9 | $175 |
| Lilly USA, LLC | 8 | $141 |
| ABBVIE INC. | 12 | $141 |
| Inspire Medical Systems, Inc. | 1 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $93 |
| Dexcom, Inc. | 4 | $88 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $69 |
| Amgen Inc. | 4 | $62 |
Products named: MOUNJARO, JARDIANCE, AIRSUPRA, INSPIRE, Dexcom G6 Transmitter, Rybelsus, Ozempic, TRELEGY ELLIPTA.
Industry payments across LA — which companies pay providers there.
